Casdin Capital’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.5M | Sell |
|
|||||
|
2025
Q1 | $13.5M | Hold |
|
|||||
|
2024
Q4 | $20.2M | Hold |
|
|||||
|
2024
Q3 | $28.8M | Sell |
|
|||||
|
2024
Q2 | $30.2M | Hold |
|
|||||
|
2024
Q1 | $26.7M | Hold |
|
|||||
|
2023
Q4 | $27.9M | Hold |
|
|||||
|
2023
Q3 | $26.8M | Hold |
|
|||||
|
2023
Q2 | $38.4M | Hold |
|
|||||
|
2023
Q1 | $30M | Hold |
|
|||||
|
2022
Q4 | $36.2M | Buy |
|
|||||
|
2022
Q3 | $30.5M | Sell |
|
|||||
|
2022
Q2 | $44.1M | Hold |
|
|||||
|
2022
Q1 | $48.3M | Hold |
|
|||||
|
2021
Q4 | $66.9M | Sell |
|
|||||
|
2021
Q3 | $85.8M | Buy |
|
|||||
|
2021
Q2 | $126M | Hold |
|
|||||
|
2021
Q1 | $91.9M | Buy |
|
|||||
|
2020
Q4 | $110M | Hold |
|
|||||
|
2020
Q3 | $46.9M | Hold |
|
|||||
|
2020
Q2 | $31.7M | Sell |
|
|||||
|
2020
Q1 | $25.5M | Buy |
|
|||||
|
2019
Q4 | $21.8M | Buy |
|
|||||
|
2019
Q3 | $9.96M | Buy |
|
|||||
|
2019
Q2 | $8.3M | Buy |
|
|||||
|
2019
Q1 | $2.32M | Hold |
|
|||||
|
2018
Q4 | $2.07M | Buy |
|